Jason Lee Epigenetics 2013

Jason Lee

Jason Lee, Ph.D., QIMR Berghofer International Research Fellow, QIMR Berghofer Medical Research Institute. Adjunct Associate Professor Queensland University of Technology. Dr Lee completed his B.Sc. (Molecular Pathology) at UNSW in 1999, and graduated with a Ph.D. in Molecular Medicine from Sydney University in 2004. He has worked at Dana Farber Cancer Institute/Harvard Medical School, Boston, where he studied the transcriptional role of cyclin D1 and estrogen receptor in breast cancer as part of a NIH program grant headed by Prof. Bob Weinberg at the Whitehead Institute, MIT. As an Associate Professor at the Chromatin Dynamics Research Center in Seoul National University, Korea, Dr Lee has gained extensive experience within the field of cancer epigenetics and transcriptional regulation. He has expertise in an array of epigenetic and molecular techniques including genome-wide analysis (RNA-seq and ChIP-seq). He is the Queensland delegate of the Australian Epigenetics Alliance (AEpiA) and a research fellow member of the ANZ Gynaecological Oncology Group and is actively studying the role of epigenetic modifiers in various cancer types including gynaecological cancers.